SynthesisThe British journal of radiology2025
Safety and efficacy of cryoablation of soft-tissue tumours: a systematic review.
Synthesis in The British journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Elastofibroma dorsi: imaging-guided minimally invasive treatment using percutaneous COSkeletal radiology · 2026Article
- Percutaneous Management of Desmoid Tumors.Current oncology reports · 2026Review
- Interventional Management of Pain with Cryoneurolysis: Expert Consensus Recommendations for Standardizing Patient Selection and Techniques Based on Delphi Process.Cardiovascular and interventional radiology · 2026Article
- Cryoablation as a downsizing strategy enabling R0 resection in a giant mediastinal desmoid tumor: a case report.Mediastinum (Hong Kong, China) · 2026Article
- Percutaneous Cryoablation of Elastofibroma Dorsi in a 73-Year-Old Woman: A Novel Minimally Invasive Alternative.Cureus · 2025Article
- Percutaneous image-guided cryoablation of venous malformation and fibro-adipose vascular anomaly: prognostic factors of clinical efficacy.European radiology · 2025Article
- Image-guided cryoablation for uterine diseases: a systematic review.Quantitative imaging in medicine and surgery · 2025Review
- Cryoablation in the treatment of early breast cancer: a comprehensive analysis.Frontiers in oncology · 2025Review
- Percutaneous cryoablation of abdominal wall endometriosis: a systematic literature review of safety and efficacy.Insights into imaging · 2024Review
- Percutaneous cryoablation in soft tissue tumor management: an educational review.Insights into imaging · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivesTo assess the safety and efficacy of percutaneous cryoablation (CA) of soft-tissue tumours [desmoid tumours (DTs), vascular malformations (VMs), and abdominal wall endometriosis (AWE)].
methodsThis systematic review of studies published before January 2024 encompassed a detailed analysis of CA techniques and technical aspects for the treatment of soft-tissue tumours. Data concerning CA efficacy, complication rates, and other relevant metrics were extracted and included for analysis.
resultsThe analysis included 27 studies totalling 554 CA procedures. For DT (13 studies, 393 sessions), CA showed an average pain reduction of 79 ± 17% (range: 57-100) and a lesion volume decrease of 71.5 ± 9.8% (range: 44-97). VM (4 studies, 58 sessions) had a 100% technical success rate and an average pain reduction of 72 ± 25% (range: 63-85). The average pain reduction for AWE (6 studies, 103 sessions) was 82 ± 13% (range: 62-100). Overall, the complication rate for CA was low, with minor adverse events (AEs) in about 20% of patients and major events in less than 5% of patients.
conclusionsShowing substantial efficacy in pain reduction and lesion volume decrease, as well as low incidence of severe AE, CA presents as a highly effective and safe alternative for the treatment of soft-tissue tumours. ADVANCES IN KNOWLEDGE: CA is effective and safe in treating soft-tissue tumours, particularly DT, VM, and AWE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.